Cargando…
Cutaneous drug eruptions associated with COVID-19 therapy
Autores principales: | Atzori, Laura, Perla, Stefania, Atzori, Maria Giovanna, Ferreli, Caterina, Rongioletti, Franco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274587/ https://www.ncbi.nlm.nih.gov/pubmed/34171032 http://dx.doi.org/10.1016/j.jdin.2020.05.004 |
Ejemplares similares
-
Clinicopathologic correlations of COVID-19–related cutaneous manifestations with special emphasis on histopathologic patterns
por: Rongioletti, Franco, et al.
Publicado: (2021) -
Don't forget about syphilis: sexually transmitted diseases during COVID-19 pandemic
por: Di Buduo, Andrea, et al.
Publicado: (2020) -
Primary Localized Cutaneous Nodular Amyloidosis and Limited Cutaneous Systemic Sclerosis: Additional Cases with Dermatoscopic and Histopathological Correlation of Amyloid Deposition
por: Atzori, Laura, et al.
Publicado: (2021) -
Fatal hyalohyphomycosis with cutaneous involvement caused by Purpureocillium lilacinum in an immunocompromised patient with bullous pemphigoid
por: Corbeddu, Marialuisa, et al.
Publicado: (2021) -
COVID-19–related skin manifestations: Update on therapy
por: Atzori, Laura, et al.
Publicado: (2021)